Description
An immunomodulator with diverse biological activities; a TLR7 agonist that inhibits RANKL-induced osteoclast differentiation of murine BMDMs; dietary administration prevents development of TCCs in a mouse model of carcinogen-induced bladder carcinoma at 200 mg/kg twice per week; reduces pulmonary collagen accumulation and BALF monocyte and eosinophil infiltration in a hamster model of bleomycin-induced lung fibrosis at 100 mg/kg; delays disease onset and progression and increases plasma IFN levels in a mouse model of EAE
Formal name: 2-amino-5-bromo-6-phenyl-4(3H)-pyrimidinone
Synonyms: ABPP|NSC 149027|PNU 54461|U-54461
Molecular weight: 266.1
CAS: 56741-95-8
Purity: ≥95%
Formulation: A crystalline solid